Unknown

Dataset Information

0

Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study.


ABSTRACT: BACKGROUND:Adrenomedullin (ADM) regulates vascular tone and endothelial permeability during sepsis. Levels of circulating biologically active ADM (bio-ADM) show an inverse relationship with blood pressure and a direct relationship with vasopressor requirement. In the present prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock 1 (, AdrenOSS-1) study, we assessed relationships between circulating bio-ADM during the initial intensive care unit (ICU) stay and short-term outcome in order to eventually design a biomarker-guided randomized controlled trial. METHODS:AdrenOSS-1 was a prospective observational multinational study. The primary outcome was 28-day mortality. Secondary outcomes included organ failure as defined by Sequential Organ Failure Assessment (SOFA) score, organ support with focus on vasopressor/inotropic use, and need for renal replacement therapy. AdrenOSS-1 included 583 patients admitted to the ICU with sepsis or septic shock. RESULTS:Circulating bio-ADM levels were measured upon admission and at day 2. Median bio-ADM concentration upon admission was 80.5 pg/ml [IQR 41.5-148.1 pg/ml]. Initial SOFA score was 7 [IQR 5-10], and 28-day mortality was 22%. We found marked associations between bio-ADM upon admission and 28-day mortality (unadjusted standardized HR 2.3 [CI 1.9-2.9]; adjusted HR 1.6 [CI 1.1-2.5]) and between bio-ADM levels and SOFA score (p < 0.0001). Need of vasopressor/inotrope, renal replacement therapy, and positive fluid balance were more prevalent in patients with a bio-ADM > 70 pg/ml upon admission than in those with bio-ADM ? 70 pg/ml. In patients with bio-ADM > 70 pg/ml upon admission, decrease in bio-ADM below 70 pg/ml at day 2 was associated with recovery of organ function at day 7 and better 28-day outcome (9.5% mortality). By contrast, persistently elevated bio-ADM at day 2 was associated with prolonged organ dysfunction and high 28-day mortality (38.1% mortality, HR 4.9, 95% CI 2.5-9.8). CONCLUSIONS:AdrenOSS-1 shows that early levels and rapid changes in bio-ADM estimate short-term outcome in sepsis and septic shock. These data are the backbone of the design of the biomarker-guided AdrenOSS-2 trial. TRIAL REGISTRATION:ClinicalTrials.gov, NCT02393781 . Registered on March 19, 2015.

SUBMITTER: Mebazaa A 

PROVIDER: S-EPMC6305573 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study.

Mebazaa Alexandre A   Geven Christopher C   Hollinger Alexa A   Wittebole Xavier X   Chousterman Benjamin Glen BG   Blet Alice A   Gayat Etienne E   Hartmann Oliver O   Scigalla Paul P   Struck Joachim J   Bergmann Andreas A   Antonelli Massimo M   Beishuizen Albertus A   Constantin Jean-Michel JM   Damoisel Charles C   Deye Nicolas N   Di Somma Salvatore S   Dugernier Thierry T   François Bruno B   Gaudry Stephane S   Huberlant Vincent V   Lascarrou Jean-Baptiste JB   Marx Gernot G   Mercier Emmanuelle E   Oueslati Haikel H   Pickkers Peter P   Sonneville Romain R   Legrand Matthieu M   Laterre Pierre-François PF  

Critical care (London, England) 20181221 1


<h4>Background</h4>Adrenomedullin (ADM) regulates vascular tone and endothelial permeability during sepsis. Levels of circulating biologically active ADM (bio-ADM) show an inverse relationship with blood pressure and a direct relationship with vasopressor requirement. In the present prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock 1 (, AdrenOSS-1) study, we assessed relationships between circulating bio-ADM during the initial intensive care unit (ICU)  ...[more]

Similar Datasets

| S-EPMC7641835 | biostudies-literature
| S-EPMC5538252 | biostudies-other
| S-EPMC7885215 | biostudies-literature
| S-EPMC7095013 | biostudies-literature
| S-EPMC4738824 | biostudies-other
| S-EPMC7193841 | biostudies-literature
| S-EPMC7095388 | biostudies-literature
| S-EPMC2887202 | biostudies-literature
| S-EPMC10160726 | biostudies-literature
| S-EPMC4796991 | biostudies-literature